Literature DB >> 8950557

Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis.

M Lebech1, D H Joynson, H M Seitz, P Thulliez, R E Gilbert, G N Dutton, B Ovlisen, E Petersen.   

Abstract

Classification systems and case definitions provide the foundations upon which clinical and epidemiological studies are based. The European Research Network on Congenital Toxoplasmosis acknowledged the lack of such a system or definitions within its field of interest and established a working group to address the issue. Congenital Toxoplasma gondii infection was defined as occurring in four separate patient groups: pregnant women, fetuses, infants, and individuals > 1 year of age. The likelihood of Toxoplasma gondii infection was separated into five mutually exclusive categories: definite, probable, possible, unlikely, and not infected. Inclusion within a specific category is dependent upon the case definition, which is in turn derived from criteria based on serological, parasitological, and clinical information. Notes are included within the classification not only to clarify the definitions, but also to improve the reliability and quality of diagnosis. The goal is to construct a system that encompasses all aspects of congenital toxoplasmosis, which is applicable to different countries and health services, suitable for large epidemiological studies, aids the diagnosis and management of individual cases, and lends itself to computerisation.

Entities:  

Mesh:

Year:  1996        PMID: 8950557     DOI: 10.1007/bf01701522

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Potential role of IgG avidity for diagnosing toxoplasmosis.

Authors:  D H Joynson; R A Payne; B K Rawal
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Prenatal diagnosis of congenital toxoplasmosis.

Authors:  G Desmonts; F Daffos; F Forestier; M Capella-Pavlovsky; P Thulliez; M Chartier
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

3.  Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii.

Authors:  B R Dannemann; W C Vaughan; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

4.  Results of 20-year follow-up of congenital toxoplasmosis.

Authors:  J G Koppe; D H Loewer-Sieger; H de Roever-Bonnet
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

5.  Chronic active toxoplasmosis in an immunocompetent patient.

Authors:  S O'Connell; E C Guy; S J Dawson; J M Francis; D H Joynson
Journal:  J Infect       Date:  1993-11       Impact factor: 6.072

6.  Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark.

Authors:  M Lebech; S O Larsen; E Petersen
Journal:  Scand J Infect Dis       Date:  1993

7.  Recent primary toxoplasma infection indicated by a low avidity of specific IgG.

Authors:  K Hedman; M Lappalainen; I Seppäiä; O Mäkelä
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

8.  Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

Authors:  C B Wilson; J S Remington; S Stagno; D W Reynolds
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

9.  IgA antibody response during acquired and congenital toxoplasmosis.

Authors:  M H Bessières; C Roques; A Berrebi; V Barre; M Cazaux; J P Séguéla
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

10.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18
View more
  49 in total

1.  Lack of value of specific IgA detection in the postnatal diagnosis of congenital toxoplasmosis.

Authors:  A K Faure; H Fricker-Hidalgo; H Pelloux; C Bost-Bru; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis.

Authors:  D Tissot Dupont; H Fricker-Hidalgo; M P Brenier-Pinchart; C Bost-Bru; P Ambroise-Thomas; H Pelloux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

3.  Diagnosis of congenital toxoplasmosis: comparison of targets for detection of Toxoplasma gondii by PCR.

Authors:  Denis Filisetti; Mohamed Gorcii; Elodie Pernot-Marino; Odile Villard; Ermanno Candolfi
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

4.  Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.

Authors:  M Lefevre-Pettazzoni; A Bissery; M Wallon; G Cozon; F Peyron; M Rabilloud
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

Review 5.  Toxoplasmosis in Germany.

Authors:  Uwe Pleyer; Uwe Gross; Dirk Schlüter; Henrik Wilking; Frank Seeber
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

6.  Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

Authors:  P A Jenum; B Stray-Pedersen
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Application and evaluation of a classification system and case definitions of Toxoplasma gondii infection.

Authors:  M Stronati; L Bollani; C Viganò; P Lanzarini; G Rondini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

8.  Comparative assessment of a commercial kit and two laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosis.

Authors:  Christelle Morelle; Emmanuelle Varlet-Marie; Marie-Pierre Brenier-Pinchart; Sophie Cassaing; Hervé Pelloux; Patrick Bastien; Yvon Sterkers
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.

Authors:  E G Lago; G S Conrado; C S Piccoli; R L Carvalho; A L Bender
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

10.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.